Comparing Hybrid Energy (OTCMKTS:HYBE) & TriSalus Life Sciences (NASDAQ:TLSI)

Hybrid Energy (OTCMKTS:HYBE) and TriSalus Life Sciences (NASDAQ:TLSI) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for Hybrid Energy and TriSalus Life Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hybrid Energy	0	0	0	0	0.00
TriSalus Life Sciences	1	0	4	0	2.60

TriSalus Life Sciences has a consensus price target of $10.50, suggesting a potential upside of 137.56%. Given TriSalus Life Sciences’ stronger consensus rating and higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than Hybrid Energy.

Valuation & Earnings

This table compares Hybrid Energy and TriSalus Life Sciences”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hybrid Energy	N/A	N/A	N/A	N/A	N/A
TriSalus Life Sciences	$29.43 million	7.49	-$30.05 million	($1.18)	-3.75

Hybrid Energy has higher earnings, but lower revenue than TriSalus Life Sciences.

Profitability

This table compares Hybrid Energy and TriSalus Life Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hybrid Energy	N/A	N/A	N/A
TriSalus Life Sciences	-86.61%	N/A	-116.50%

Insider and Institutional Ownership

2.6% of TriSalus Life Sciences shares are held by institutional investors. 6.0% of Hybrid Energy shares are held by insiders. Comparatively, 27.5% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

TriSalus Life Sciences beats Hybrid Energy on 6 of the 8 factors compared between the two stocks.

About Hybrid Energy

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.